Tech Company Financing Transactions
Sagent Pharmaceuticals Funding Round
Vivo Capital and private investors joined a $53 million Series A capital raise for Sagent Pharmaceuticals. This VC investment round was announced by the company on 9/27/2007.
Transaction Overview
Company Name
Announced On
9/27/2007
Transaction Type
Venture Equity
Amount
$53,000,000
Round
Series A
Investors
Vivo Capital (Lead Investor)
Proceeds Purpose
Proceeds from the financing will be used primarily to fund near-term product launches, product development activities and strategic business initiatives, including numerous development, sales and marketing, manufacturing and distribution partnerships.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1901 N. Roselle Rd. 450
Schaumburg, IL 60195
USA
Schaumburg, IL 60195
USA
Phone
Website
Email Address
Overview
SAGENT is a forward-thinking specialty injectables company that goes beyond just listening to what our customers have to say. We're committed to responding to what we hear. With speed, with flexibility, and with efficiency.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Yordon
Browse more venture capital transactions:
Prev: 9/27/2007: DECA venture capital transaction
Next: 9/28/2007: Intersect ENT venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs